IGM Biosciences to Participate in Three Upcoming Investor Conferences

Rhea-AI Summary

IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology firm, announced participation in three investor conferences: the Citi 16th Annual BioPharma Virtual Conference on September 9, the Morgan Stanley 19th Annual Global Healthcare Conference on September 13 at 2:45 p.m. EDT, and Baird’s 2021 Global Consumer, Technology & Services Conference on September 14 at 2:35 p.m. EDT. A live webcast of the Morgan Stanley chat will be available on the company’s website, with a replay archived for 90 days.

MOUNTAIN VIEW, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that management will participate in three upcoming investor conferences:

• Citi 16^th Annual BioPharma Virtual Conference on Thursday, September 9
• Fireside chat at the Morgan Stanley 19^th Annual Global Healthcare Conference on Monday, September 13 at 2:45 p.m. EDT
• Fireside chat at Baird’s 2021 Global Consumer, Technology & Services Conference on Tuesday, September 14 at 2:35 p.m. EDT
  

A live webcast of the Morgan Stanley fireside chat will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investor.igmbio.com/news-and-events/events-and-presentations. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.

About IGM Biosciences, Inc.
Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.

Contact:

Argot Partners
David Pitts
212-600-1902
igmbio@argotpartners.com

FAQ

What conferences is IGM Biosciences participating in this September 2021?

IGM Biosciences is participating in the Citi 16th Annual BioPharma Virtual Conference on September 9, the Morgan Stanley 19th Annual Global Healthcare Conference on September 13 at 2:45 p.m. EDT, and Baird’s 2021 Global Consumer, Technology & Services Conference on September 14 at 2:35 p.m. EDT.

Where can I find the live webcast for the Morgan Stanley conference?

The live webcast for the Morgan Stanley conference will be available on IGM Biosciences' 'Events and Presentations' page in the 'Investors' section of their website.

How long will the Morgan Stanley conference replay be available?

The replay of the Morgan Stanley conference webcast will be archived on IGM Biosciences' website for 90 days following the presentation.

What is the focus of IGM Biosciences as a biotechnology company?

IGM Biosciences focuses on creating and developing engineered IgM antibodies for therapeutic use, overcoming manufacturing and protein engineering challenges.

What is the stock symbol for IGM Biosciences?

The stock symbol for IGM Biosciences is IGMS.